Laezza, Chiara <br/><br/>
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.  [electronic resource] 

 -  Journal of molecular medicine (Berlin, Germany)  Nov 2006 
 - 967-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0946-2716 
<br/><br/><label>Standard No.: </label>10.1007/s00109-006-0079-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Flavonoids--pharmacology<br/>Gene Transfer Techniques<br/>Goiter--chemically induced<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hyperplasia<br/>Hypertrophy<br/>Lovastatin--pharmacology<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Phosphorylation<br/>Proliferating Cell Nuclear Antigen--analysis<br/>Propylthiouracil<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Prenylation--drug effects<br/>Rats<br/>Rats, Wistar<br/>Terpenes--metabolism<br/>Thyroid Gland--drug effects<br/>Thyrotropin--blood<br/>ras Proteins--genetics